Dr Vojo Vukovic joins Synta
This article was originally published in Scrip
Executive Summary
Synta Pharmaceuticals, a US biopharmaceutical company focused on discovering, developing and commercialising small-molecule drugs to treat severe medical conditions, has appointed Dr Vojo Vukovic vice-president of clinical research. He will be the medical lead for the company's most advanced oncology product candidate, elesclomol. Dr Vukovic has more than 15 years' experience in oncology drug development and joins from Pfizer, where he was global medical lead for Sutent and axitinib in a number of cancer indications.